MAIA Biotechnology, Inc.
Biotechnology
444 West Lake Street
26 employees
AMERI
- Employees
- 26
- Contacts
- 2
- Emails
- 2
MAIA Biotechnology, Inc. Overview
- Headquarters
- 444 West Lake Street
- Website
- maiabiotech.com
- Industry
- Biotechnology
- Employees
- 26
- Founded
- 2018
- Stock Symbol
- AMERI
- Funding
- 695.0K
- Company Email
- Available in AeroLeads
About MAIA Biotechnology, Inc.
MAIA Biotechnology is a targeted therapy, immune-oncology company, focused on development and commercialization of first-in-class drugs with novel mechanisms of action that are intended to meaningfully improve and extend the lives of people with cancer. A publicly traded company based in Chicago, MAIA (NYSE American: MAIA) is led by a passionate, principled and highly experienced Management Team with significant drug development experience, committed to advancing promising agents into human clinical trials. MAIA’s business strategy is designed to advance a strong value proposition for its portfolio of potentially novel compounds. MAIA controls risk and enhances its opportunity for success by diversifying and generating this portfolio of assets with a variety of compounds with novel mechanisms of action which have potential activity in multiple tumor types. MAIA’s business model involves placing drug candidates in their own dedicated, R&D focused subsidiary company, which is supported by the common infrastructure, management team, and resources of the MAIA enterprise. This model allows MAIA to provide more focused R&D support to each drug candidate, while also distributing shared central resources among subsidiary companies to maintain a lean, capital-efficient operating structure.
MAIA Biotechnology, Inc. Contact Details
- People in AeroLeads
- 4
- With contact data
- 2
- Email contacts
- 2
- 50.0% coverage
MAIA Biotechnology, Inc. Org Chart
Sample employees and titles| Name | Title | Location | Contact |
|---|---|---|---|
| K. Robinson Lewis | Vice President, Head of Regulatory | Raleigh, North Carolina, United States |
Email
|
| Sergei Gryaznov | Greater Chicago Area, United States |
Email
|
|
| Stan V. Smith, Ph.d. | President and CEO - Smith Economics |
View
|
|
| Jean-Manassé Théagène | Executive - Board Member I |
View
|
Employees by Management Level
Executive
3 profiles
Director
2 profiles
VP / Head
1 profile
Manager
1 profile
Individual contributor
1 profile
Department Contact Coverage
| Department | Contacts | Phone | |
|---|---|---|---|
| Executive | 3 | 3 | 1 |
| Healthcare | 1 | 1 | 0 |
| General | 1 | 1 | 0 |
Compare Similar Companies to MAIA Biotechnology, Inc.
Xeris Pharmaceuticals, Inc.
Pharmaceutical Manufacturing
Evozyne
Biotechnology
MAIA Pharmaceuticals
Pharmaceutical Manufacturing
Emalex Biosciences
Biotechnology Research
Vanqua Bio
Biotechnology Research
Paragon Biosciences
Biotechnology Research
Grove Biopharma, Inc.
Biotechnology Research
CiRC Biosciences
Biotechnology Research
Exicure
Biotechnology Research
GENZ Biotechnology
Biotechnology Research